(Q43507367)

English

Stereochemistry of halopyridyl and thiazolyl thiourea compounds is a major determinant of their potency as nonnucleoside inhibitors of HIV-1 reverse transcriptase

scientific article published in September 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Stereochemistry of halopyridyl and thiazolyl thiourea compounds is a major determinant of their potency as nonnucleoside inhibitors of HIV-1 reverse transcriptase (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

author name string

Venkatachalam TK

1

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Sudbeck EA

2

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Mao C

3

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Uckun FM

4

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

language of work or name

0 references

publication date

1 September 2000

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Bioorganic & Medicinal Chemistry Letters

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

2071-2074

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Rational design and synthesis of phenethyl-5-bromopyridyl thiourea derivatives as potent non-nucleoside inhibitors of HIV reserve transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900398-X

7 January 2021

based on heuristic

inferred from DOI database lookup

5-Alkyl-2-[(methylthiomethyl)thio]-6-(benzyl)-pyrimidin-4-(1H)-ones as potent non-nucleoside reverse transcriptase inhibitors of S-DABO series

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900398-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Structure-based design of N-[2-(1-piperidinylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea and N-[2-(1-piperazinylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea as potent non-nucleoside inhibitors of HIV-1 reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900398-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Structure-based design of novel dihydroalkoxybenzyloxopyrimidine derivatives as potent nonnucleoside inhibitors of the human immunodeficiency virus reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900398-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Rational design of N-[2-(2,5-dimethoxyphenylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea (HI-236) as a potent non-nucleoside inhibitor of drug-resistant human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900398-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Structure-based design of non-nucleoside reverse transcriptase inhibitors of drug-resistant human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900398-X

7 January 2021

based on heuristic

inferred from DOI database lookup

N-[2-(1-cyclohexenyl)ethyl]-N'-[2-(5-bromopyridyl)]-thiourea and N'-[2-(1-cyclohexenyl)ethyl]-N'-[2-(5-chloropyridyl)]-thiourea as potent inhibitors of multidrug-resistant human immunodeficiency virus-1

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900398-X

7 January 2021

based on heuristic

inferred from DOI database lookup

N'-[2-(2-thiophene)ethyl]-N'-[2-(5-bromopyridyl)] thiourea as a potent inhibitor of NNI-resistant and multidrug-resistant human immunodeficiency virus-1

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900398-X

7 January 2021

based on heuristic

inferred from DOI database lookup

N-[2-(4-methylphenyl)ethyl]-N'-[2-(5-bromopyridyl)]-thiourea as a potent inhibitor of NNRTI-resistant and multidrug-resistant human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900398-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0960-894X(00)00398-X

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43507367&oldid=2136749331"